Reply:

References

1. ↵
   Zhang PJ, Rosenblum MK. Synaptophysin expression in the human spinal cord. Diagnostic implications of an immunohistochemical study. Am J Surg Pathol 1996;20:273-276

   PubMed
2. ↵
   Norenberg MD. Gangliogliomas: issues of prognosis and treatment. AJNR Am J Neuroradiol 1998;19:810

   PubMed
3. ↵
   Miller DC, Rorke LB, Weinberg J, Allan JC, Epstein FJ. Histopathologic diagnoses of intramedullary spinal cord tumors in children. J Neuropath Exper Neurol 1997;56:607
4. ↵
   Wolf HK, Muller MB, Spanle M, et al. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. . Acta Neuropathol 1994;88:166-173

   PubMed
5. ↵
   Diepholder HM, Schweckheimer K, Mohadjer M, Knoth R, Vlk B. A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma. Cancer 1991;68:2192-2201

   CrossRefPubMed
6. Isimbaldi G, Sironi M, Tonnarelli GP, Roncoroni M, Declich P, Galli C. Ganglioglioma: A clinical and pathological study of 12 cases. Clin Neuropathol 1996;15:192-199

   PubMed
7. ↵
   Hirose T, Scheithauer BW, Lopes MBS, et al. Ganglioglioma: an ultrastructural and immunohistochemical study. . Cancer 1997;79:989-1003

   CrossRefPubMedWeb of Science
8. Büttner A, Bavbeck B, Winkler PA, Mehraein P, Weis S. Ganglioglioma: A clinicopathological study of 10 cases. Neuropathol 1997;17:94-100
9. ↵
   Miller DC, Lang FF, Epstein FJ. Central nervous system gangliogliomas, 1: pathology. J Neurosurg 1993;79:859-866

   PubMedWeb of Science
10. Jaffrey PB, Mundt AJ, Baunoch DA, et al. The clinical significance of extracellular matrix in gangliogliomas. 1996;55:1246-1252